Raphael Pharmaceutical (RAPH) Notes Payables (2020 - 2025)
Raphael Pharmaceutical (RAPH) posted Notes Payables of $946000.0 for Q4 2025, up 25.3% sequentially from $755000.0 in Q3 2025, and up 2207.32% YoY from $41000.0 in Q4 2024.
Raphael Pharmaceutical (RAPH) Notes Payables (2020 - 2025) Analysis & Trends
Raphael Pharmaceutical has reported Notes Payables for 5 years, with the latest figure at $946000.0 in Q4 2025.
- Quarterly Notes Payables rose 2207.32% year-over-year to $946000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $946000.0 (up 2207.32% YoY) and the FY2025 annual result came in at $946000.0, up 2207.32% from the prior year.
- Notes Payables rose to $946000.0 in Q4 2025 per RAPH's latest filing, from $755000.0 in the prior quarter.
- Over five years, Notes Payables peaked at $946000.0 in Q4 2025 and troughed at $3000.0 in Q4 2022.
- A 4-year average of $178083.3 and a median of $40500.0 in 2023 frame the typical range for Notes Payables.
- The sharpest annual moves came in 2024 and 2025: Notes Payables plunged 33.33% in 2024, then soared 2207.32% in 2025.
- Over 4 years, Notes Payables stood at $3000.0 in 2022, then jumped by 1166.67% to $38000.0 in 2023, then increased by 7.89% to $41000.0 in 2024, then jumped by 2207.32% to $946000.0 in 2025.
- According to Business Quant data, Notes Payables over the past three periods registered $946000.0, $755000.0, and $41000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | Raphael Pharmaceutical | 28.25 Mn | 28.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 946,000.00 |
| Sep 30, 2025 | 755,000.00 |
| Jun 30, 2025 | 41,000.00 |
| Mar 31, 2025 | 41,000.00 |
| Dec 31, 2024 | 41,000.00 |
| Sep 30, 2024 | 130,000.00 |
| Jun 30, 2024 | 26,000.00 |
| Mar 31, 2024 | 37,000.00 |
| Dec 31, 2023 | 38,000.00 |
| Sep 30, 2023 | 40,000.00 |
| Jun 30, 2023 | 39,000.00 |
| Dec 31, 2022 | 3,000.00 |
| Dec 31, 2020 | 357,000.00 |